the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
27.5 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

Govt must explore new growth areas immediately, improve export performance

KUALA LUMPUR: Immediate action to explore new growth areas must be undertaken in tandem with the empowerment of the main sectors, said Datuk Mohd Shahar Abdullah (pix)(BN-Paya Besar).

Mohd Shahar, who is also the Special Select Committee On Finance and Economy chairman, said the export of electronic products and commodities to new markets must also be undertaken immediately without dependency on existing markets.

“We cannot solely depend on foreign direct investments (FDI). Instead, efforts to intensify and spur domestic investment must be the priority.

“The government needs to determine the incentives and attractions that can be provided to attract investor interest in the country’s equity and capital markets,“ he said when debating the Royal Address in the Dewan Rakyat today.

Regarding Malaysia’s 2023 economic growth of 3.7 per cent, below the targeted 4.0 per cent, Mohd Shahar said this was related to the decline in the country’s exports, although the impact from external factors was mitigated by the strong domestic demand.

He said there must be a plan to improve the situation so that the balance in the current account does not continue its downward trend.

“I believe that this can be improved if the export performance is dominated by manufacturing high-quality products and maintaining competitive pricing, as well as driving innovation and productivity through research and development in high-value manufacturing sectors,“ he added. –Bernama

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Addressing medical inflation

Consumers are struggling as medical insurance premiums surge, with over 340,000 dropping coverage amid calls for price regulation and stronger public healthcare

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings